Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis Counting On Depth Of Insight To Continue Success In Oncology

Jul 29 2013

• By Shirley Haley

Related Content

As Sun Sets On <em>Gleevec</em>, Novartis Looks To New Horizons In Oncology

Nov 19 2012

Novartis Brings “Disruptive Innovation” To Clinical Trials

Nov 19 2012

Novartis Sees Targeted Combinations As Wave Of The Future In Oncology

Nov 01 2012

New Drugs Build On Personalized Medicine Momentum In Lung Cancer

Oct 08 2012

<em>Afinitor</em> Adds Breast Cancer Indication On Strength Of Progression-Free Survival Benefit

Jul 20 2012

Incyte’s <em>Jakafi</em> Gets Broad Label, Early Approval For Myelofibrosis

Nov 16 2011

Novartis Rx Exec Changes Include U.S. COO Epstein To Oncology Unit Head

Jul 17 2000

Related Companies

Novartis AG

Roche Holding AG

Pfizer Inc.

Ligand Pharmaceuticals, Inc.

GSK plc

AstraZeneca PLC

Bayer AG

Onyx Pharmaceuticals, Inc.

Additional Topics

Clinical Trials BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window